Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought
to you by the National Network for Immunization Information (NNii). Visit NNii's
new website at
http://www.immunizationinfo.org.
Information technology services firm Computer
Sciences has announced that its DynPort Vaccine, a joint venture with Porton
International, has proven promising in preliminary tests. According to reports,
a trial of the cell-cultured vaccine had encouraging results. In addition, the
trial of 350 patients showed that risk of side effects like nausea was reduced
in patients taking the DynPort vaccine than the traditional Dryvax. Computer
Sciences controls 51 percent of the venture and Porton International the other
49 percent.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"